EC AUTOBIO 2 a Series of CGF2021 LLC has announced a new private equity fund offering through a recent filing. The company aims to raise a total of $178,000, which has already been fully subscribed. This move is significant as it underscores the continued interest in pooled investment funds within the investment industry.
EC AUTOBIO 2 a Series of CGF2021 LLC, incorporated in Delaware, is categorized as a limited liability company. The company’s recent filing, dated October 22, 2026, is a Form D, which is typically used to report exempt offerings of securities. The company has not disclosed its SIC code or any specific competitors in the filing.
The filing indicates that the offering is made under Rule 506(b), which provides a safe harbor for private offerings. According to the filing, the total offering amount is $178,000, and it has already been fully sold. The filing also notes that there are no sales commissions or finders' fees associated with this offering.
This offering may primarily affect accredited investors, as the company reported that there are no non-accredited investors involved. The total number of investors who have already invested in the fund is three, indicating a small but potentially focused group of participants.
As for the next steps, the filing does not specify any forthcoming actions or additional filings. However, the successful completion of this offering could lead to further investment opportunities or expansions for EC AUTOBIO 2 a Series of CGF2021 LLC in the future.